Marlins DFA 2025 Tigers trade acquisition in another knock for Scott Harris

The latest chapter in Scott Harris’ roster-building ledger just took another hit — and this one aged quickly.

The Miami Marlins are designating Chris Paddack for assignment — a reminder of how little the Detroit Tigers ultimately got out of a move that, at the time, felt like a reasonable gamble on pitching depth.

Paddack, now 30, arrived in Detroit at last year’s deadline as part of a broader effort to stabilize a staff that needed innings. Instead, he gave them very little certainty — and even less upside. The Tigers quickly shifted him to the bullpen after just seven starts, a quiet but telling admission that the rotation experiment wasn’t working.

Now, less than a year later, he’s being cut loose by Miami after posting a 7.63 ERA across seven appearances.

That’s the problem. Not that Paddack failed — pitchers with his injury history flame out all the time — but that there was never much margin for error in the first place.

Harris has built his reputation on threading needles: buying low, optimizing player traits, and trusting development infrastructure. When it works, it looks like a masterclass. But when it doesn’t, the misses can feel avoidable because they hinge on such narrow projections.

Paddack was one of those bets.

Scott Harris' 2025 trade deadline disaster rears its ugly head as Marlins DFA Chris Paddack

Paddack's underlying profile hasn’t changed much since his standout 2019 rookie year with the San Diego Padres. He throws strikes. He limits walks. But he doesn’t miss enough bats, and when he’s off, the ball leaves the yard in a hurry. Layer on multiple arm injuries — including two Tommy John surgeries — and the risk becomes obvious.

Detroit bet they could either unlock something or at least extract useful innings. They got neither.

And in a vacuum, that’s fine. Deadline deals miss all the time. But zoom out, and it adds to a growing list of moves that haven’t meaningfully pushed the Tigers forward. For a front office that prides itself on incremental gains, dead-end acquisitions like Paddack matter more than they should.

The most frustrating part is that there was a version of this that made sense — just not the one Detroit chose. Paddack has shown flashes of effectiveness in shorter stints, particularly post-surgery with Minnesota. A defined bullpen role might have maximized what he still does well. Instead, he was stretched, exposed, and ultimately discarded.

Now the Marlins will eat the remaining salary, and another team might take a low-cost flier. That’s the lifecycle of pitchers like Paddack.

But for the Tigers, it’s another reminder: the margin between a savvy buy-low and a wasted move is razor thin — and lately, too many of those bets are landing on the wrong side.

Add us as a preferred source on Google

Follow